Evidence map›Paper›PMID 36835247›Full record

ArticleInternational journal of molecular sciences2023

Characterization of the Antitumor Potential of Extracts of

Laura Sánchez-Sánchez, Javier García, Roberto Fernández, Ekaterina Noskova, June Egiguren-Ortiz, Marina Gulak, Eneko Ochoa, Antonio Laso, Mikel Oiarbide, José Ignacio Santos and 5 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. New Cannabinoids and Chlorin-Type Metabolites from the Flowers ofPharmaceuticals (Basel, Switzerland) · 2025
    Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 1 country.

Laura Sánchez-SánchezResearch and Development Department, IMG Pharma Biotech S.L., 48160 Derio, Spain.ORCID 0000-0001-5777-6588
Javier GarcíaInstitute of Agricultural Sciences (ICA), Spanish Research Council (CSIC), 28006 Madrid, Spain.
Roberto FernándezResearch and Development Department, IMG Pharma Biotech S.L., 48160 Derio, Spain.ORCID 0000-0002-3424-9758
Ekaterina NoskovaResearch and Development Department, IMG Pharma Biotech S.L., 48160 Derio, Spain.
June Egiguren-OrtizResearch and Development Department, IMG Pharma Biotech S.L., 48160 Derio, Spain.
Marina GulakCruz Roja Hospital, 48001 Bilbao, Spain.
Eneko OchoaPharmacology Department, Faculty of Medicine and Nursing, University of the Basque Country UPV/EHU, 48940 Leioa, Spain.
Antonio LasoResearch and Development Division, AleoVitro, 48160 Derio, Spain.
Mikel OiarbidePharmacology Department, Faculty of Medicine and Nursing, University of the Basque Country UPV/EHU, 48940 Leioa, Spain.ORCID 0000-0003-0362-0136
José Ignacio SantosPharmacology Department, Faculty of Medicine and Nursing, University of the Basque Country UPV/EHU, 48940 Leioa, Spain.ORCID 0000-0002-5199-2332
María Fe AndrésInstitute of Agricultural Sciences (ICA), Spanish Research Council (CSIC), 28006 Madrid, Spain.ORCID 0000-0002-8729-5053
Azucena González-ColomaInstitute of Agricultural Sciences (ICA), Spanish Research Council (CSIC), 28006 Madrid, Spain.ORCID 0000-0001-5124-664X
Albert AdellInstituto de Biomedicina y Biotecnología de Cantabria (IBBTEC), Consejo Superior de Investigaciones Científicas (CSIC), University of Cantabria, 39011 Santander, Spain.ORCID 0000-0003-0570-4931
Egoitz AstigarragaResearch and Development Department, IMG Pharma Biotech S.L., 48160 Derio, Spain.ORCID 0000-0002-0338-5554
Gabriel Barreda-GómezResearch and Development Department, IMG Pharma Biotech S.L., 48160 Derio, Spain.ORCID 0000-0002-8330-1567
University of the Basque Country · ESInstituto de Ciencias Agrarias · ESUniversidad de Cantabria · ESHospital Central de la Cruz Roja San José y Santa Adela · ESUniversidad de Valladolid · ES

Funding

Basque Government Department of Economic Development, Sustainability and Environment Bikaintek program: 005-B2/2021Ministry of Economy and Competitiveness DIN2019-010902Ministry of Economy and Competitiveness DIN2020-011349
6 · The paper itself

Abstract

Cannabis has been used for decades as a palliative therapy in the treatment of cancer. This is because of its beneficial effects on the pain and nausea that patients can experience as a result of chemo/radiotherapy. Tetrahydrocannabinol and cannabidiol are the main compounds present in

Indexed as

CannabisNeuroblastomaPlant ExtractsCannabidiolCannabinoidsDronabinolElectron Transport Complex IVHumansCannabidiolCannabinoidsDronabinolElectron Transport Complex IVPlant Extractsantitumorcannabisextractsneuroblastoma

Identifiers

PMID36835247
PMCPMC9964014
OpenAlexW4320920257

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.